These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 437435)
1. Complement alterations in inflammatory bowel disease. Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435 [TBL] [Abstract][Full Text] [Related]
2. Humoral immune system in inflammatory bowel disease: I. Complement levels. Hodgson HJ; Potter BJ; Jewell DP Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196 [TBL] [Abstract][Full Text] [Related]
3. Humoral immune system activity in inflammatory bowel disease. Teisberg P; Gjone E Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519 [TBL] [Abstract][Full Text] [Related]
4. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency. Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513 [TBL] [Abstract][Full Text] [Related]
5. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus. Whaley K; Schur PH; Ruddy S Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347 [TBL] [Abstract][Full Text] [Related]
6. Haemolytic complement in peripheral lymph of normal men. Olszewski WL; Engeset A Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278 [TBL] [Abstract][Full Text] [Related]
7. Alternative pathway complement activation in rheumatoid arthritis. El-Ghobarey A; Whaley K J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571 [TBL] [Abstract][Full Text] [Related]
8. Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease. Ward M; Eastwood MA Gut; 1974 Oct; 15(10):835. PubMed ID: 4215646 [No Abstract] [Full Text] [Related]
9. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis. Whaley K; Ward D; Ruddy S Clin Exp Immunol; 1979 Jan; 35(1):101-6. PubMed ID: 85507 [TBL] [Abstract][Full Text] [Related]
10. Complement abnormalities during an epidemic of group B meningococcal infection in children. Beatty DW; Ryder CR; Heese HD Clin Exp Immunol; 1986 Jun; 64(3):465-70. PubMed ID: 3491693 [TBL] [Abstract][Full Text] [Related]
11. Complement activation during CAPD. Young GA; Kendall S; Brownjohn AM Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307 [TBL] [Abstract][Full Text] [Related]
12. Humoral immune system and ulcerative colitis activity. II. Complement level. Hermanowicz A; Sliwiński Z; Nawarska Z; Banaś B Arch Immunol Ther Exp (Warsz); 1984; 32(5):509-14. PubMed ID: 6152530 [TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative pathway of complement in childhood acute lymphoblastic leukemia. Kalwinsky DK; Urmson JR; Stitzel AE; Spitzer RE J Lab Clin Med; 1976 Nov; 88(5):745-56. PubMed ID: 1068203 [TBL] [Abstract][Full Text] [Related]
14. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum. Nakajima S; Baba AS; Tamura N Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627 [TBL] [Abstract][Full Text] [Related]
15. The effect of aging on complement activity (CH50) and complement protein levels. Nagaki K; Hiramatsu S; Inai S; Sasaki A J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926 [TBL] [Abstract][Full Text] [Related]
16. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae. Densen P; McRill CM; Ross SC J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507 [TBL] [Abstract][Full Text] [Related]
17. Serum complement components in Henoch-Schönlein purpura. Garcia-Fuentes M; Martin A; Chantler C; Williams DG Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358 [TBL] [Abstract][Full Text] [Related]
18. Alterations of complement components in disease. Luskin AT; Tobin MC Am J Med Technol; 1982 Sep; 48(9):749-56. PubMed ID: 6215862 [No Abstract] [Full Text] [Related]
19. The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein. Feinstein PA; Kaplan SR; Thayer WR Gastroenterology; 1976 Feb; 70(2):181-5. PubMed ID: 2509 [TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative pathway of complement by Entamoeba histolytica. Ortiz-Ortiz L; Capin R; Capin NR; Sepúlveda B; Zamacona G Clin Exp Immunol; 1978 Oct; 34(1):10-8. PubMed ID: 219975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]